Structural Biology – News and Features

Clarient licenses HDC's Support Vector Machine patent portfolio in the field of peripheral rare cell detection.

The agreement focuses on co-crystallography by ActiveSight of certain Inpharmatica small molecules.

The facility will combine technological advances in new ways to transform proteins into crystals.

Sareum will provide protein structure determination capabilities to accelerate drug discovery research at Schering.

The event highlighted the latest research as well as exploring the ongoing challenges and bottlenecks facing the industry.

The disorder is caused by a mutation in an integral component of a four-protein complex.

Researchers have identified a two-protein complex which controls the earliest steps in the creation of miRNAs.

A sharper picture of the nano-machine promises to help researchers explain how some types of antibiotics work

ActiveSight will advance Ambit's drug discovery program.

The aim of collaboration is to prioritise proteins as drug targets.